U.S. Markets open in 8 hrs 13 mins

China Biologic Products Holdings, Inc. (CBPO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
118.00-0.03 (-0.03%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close118.03
Open118.82
Bid0.00 x 1300
Ask0.00 x 1100
Day's Range117.89 - 118.27
52 Week Range99.13 - 120.01
Volume18,406
Avg. Volume156,745
Market Cap4.577B
Beta (5Y Monthly)0.42
PE Ratio (TTM)30.89
EPS (TTM)3.82
Earnings DateMay 18, 2021 - May 24, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est102.78
  • China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
    PR Newswire

    China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020

    China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2020.

  • 10 Best Hong Kong Stocks To Buy For 2021
    Insider Monkey

    10 Best Hong Kong Stocks To Buy For 2021

    In this article, we discussed Chinese billionaire Zhang Lei’s investment philosophy and his 10 best Hong Kong stocks to buy for 2021. Click to skip ahead and see 5 Best Hong Kong Stocks To Buy for 2021. Hillhouse Capital Group founder and Chinese billionaire Zhang Lei has generated strong returns over the years amid his […]

  • China Biologic Announces Shareholders' Approval of Merger Agreement
    PR Newswire

    China Biologic Announces Shareholders' Approval of Merger Agreement

    China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the "EGM") held today, the Company's shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the "Merger Agreement"), among the Company, CBPO Holdings Limited ("Parent") and CBPO Group Limited ("Merger Sub"), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the "Merger"), the plan of merger (the "Plan of Merger") required to be filed with the Registrar of Companies of the Cayman Islands, and the transactions contemplated thereby, including the Merger.